MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-28 Cr | ₹-37 Cr | ₹76 Cr | ₹19 Cr | ₹155 Cr |
What is the latest Net Cash Inflow / Outflow ratio of MANKIND PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-28 Cr |
| Mar2025 | ₹-37 Cr |
| Mar2024 | ₹76 Cr |
| Mar2023 | ₹19 Cr |
| Mar2022 | ₹155 Cr |
How is Net Cash Inflow / Outflow of MANKIND PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-28 Cr | Negative | |
| Mar2025 | ₹-37 Cr | Negative | |
| Mar2024 | ₹76 Cr | 290.95 | |
| Mar2023 | ₹19 Cr | -87.48 | |
| Mar2022 | ₹155 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹102,421.9 Cr | 2.1% | 7.1% | -0.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,562.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,572.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,871.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹107,770.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,829.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 2.1% |
7.1% |
-0.6% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses